Reunion Neuroscience Inc.
REUN · NASDAQ
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $10,860 | $14,192 | $23,017 | $62,885 |
| - Cash | $27,200 | $31,871 | $28,432 | $40,394 |
| + Debt | $3,368 | $5,466 | $1,935 | $0 |
| Enterprise Value | -$12,972 | -$12,213 | -$3,480 | $22,491 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$8,264 | -$8,691 | -$7,413 | -$3,997 |
| % Margin | – | – | – | – |
| Net Income | -$6,229 | -$12,688 | -$23,890 | -$5,237 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.54 | -1.09 | -2.05 | -0.45 |
| % Growth | 50.5% | 46.8% | -355.6% | – |
| Operating Cash Flow | -$4,421 | -$4,404 | -$8,382 | -$10,710 |
| Capital Expenditures | $0 | $0 | -$176 | -$70 |
| Free Cash Flow | -$4,421 | -$4,404 | -$8,558 | -$10,780 |